Fielder Capital Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$303K Buy
3,506
+901
+35% +$79.4K 0.06% 213
2026
Q2
$204K Buy
+2,605
New +$210K 0.04% 288
2026
Q1
– Sell
-2,528
Closed -$243K – 304
2025
Q4
$243K Sell
2,528
-419
-14% -$40.7K 0.05% 235
2025
Q3
$281K Buy
+2,947
New +$271K 0.06% 185
2024
Q4
– Sell
-2,506
Closed -$226K – 225
2024
Q3
$226K Sell
2,506
-150
-6% -$12.6K 0.07% 179
2024
Q2
$209K Sell
2,656
-56
-2% -$4.59K 0.08% 178
2024
Q1
$236K Sell
2,712
-19
-0.7% -$1.62K 0.11% 135
2023
Q4
$225K Buy
+2,731
New +$208K 0.14% 123

Other funds holding MDT

Fielder Capital Group's MDT Position: Q3 2026 in Review

Fielder Capital Group increased its Medtronic (MDT) stake by 35% in Q3 2026, buying an estimated $79.4K and bringing the position to 3,506 shares worth $303K. The position accounts for 0.06% of the portfolio, ranked #213.

Fielder Capital Group first reported a position in MDT in Q4 2023 and has held it in 8 quarters since. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Fielder Capital Group held 3,506 shares of Medtronic worth $303K as of Q3 2026.
  • Fielder Capital Group bought 901 Medtronic shares in Q3 2026, an estimated $79.4K.
  • Medtronic made up 0.06% of Fielder Capital Group's portfolio in Q3 2026, its #213 holding.
  • Fielder Capital Group first reported a position in Medtronic in Q4 2023 and has held it in 8 quarters since.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Fielder Capital Group's 13F filing for Q3 2026, filed 12 Nov 2026.